Browse studies

Find your next paid study

27,293 recruiting studies available now

Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease

The purpose of the study is to determine which combination of neuromuscular blocking agent and reversal agent is safer to use during anesthesia for patients wi…

Post Operative Pulmonary ComplicationsNeuromuscular BlockadeGeneral Anesthesia

Estimated

~$25 – $1,000

Actual pay is set by the research site.

The University of Texas Medical Branch, GalvestonNCT07203287

Observational

I CARE (Immunotherapy Cutaneous Adverse Events REsearch) - A Trial With Diverse Cancer Patients to Determine the Impact of SDoH and Side Effects Navigation Program on Treatment Continuation

The purpose of this study is to find out if the navigation program helps participants manage immunotherapy treatment better than usual care. Investigators will…

Kidney CancerBladder CancerBreast Cancer+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT07646847

Phase 1

A Phase 1b, Randomized, Placebo-Controlled, Participant and Investigator-Blinded, Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Cytochrome P450 Interaction of Orally Administered LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis

The main purpose of this study in participants with Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS) is to test the safety of different doses and to de…

Amyotrophic Lateral SclerosisCytochrome P-450 Enzyme System

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Eli Lilly and CompanyNCT07883590

Observational

The Effects of Vagus Nerve Stimulation on Intrinsic Lower Leg Spinal Motoneuron Excitability in Parkinson's Disease.

This study is designed to better understand the mechanisms contributing to impaired activation of leg muscles in people with Parkinson's disease (PD) and to te…

PARKINSON DISEASE (Disorder)Parkinson's Disease (PD)

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MinnesotaNCT07226284

Phase 1

First in Human Phase 1 Study of AOH1996 in Patients With Refractory Solid Tumors

This phase I trial studies the side effects and best dose of AOH1996 in treating patients with solid tumors that do not respond to treatment (refractory). AOH1…

Refractory Malignant Solid NeoplasmOsteosarcomaLeiomyosarcomas+4 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

City of Hope Medical CenterNCT05227326

Umbrella Long-Term Follow-Up Protocol

This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology…

Hematopoietic Cell Transplantation RecipientLeukemiaSolid Tumor

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Children's Oncology GroupNCT00736749

Observational

STOP (Shared Decision Making to Treat Or Prevent) HIV in Criminal Legal Involved Populations

This study seeks to compare the effectiveness of two Patient Navigation models of care to evaluate the proportion who initiate PrEP/ART and substance use/subst…

Substance Use Disorders

Estimated

~$10 – $750

Actual pay is set by the research site.

Yale UniversityNCT07223398

Phase 1

Open Label, Multicenter, Dose-escalation and Cohort-expansion Phase I/IIA Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer (CRC) - BreAK CRC Trial (BreAK for Brenus Anti-cancer)

This is a phase I/IIA, first-in-human (FIH), two-part, open-label, multicenter study to characterize the safety, tolerability profile, and clinical efficacy of…

Unresectable Metastatic Colorectal CancerUnresectable Locally Advanced Colorectal Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Brenus PharmaNCT06934538

Phase 2

A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy

Background: Prostate cancer is often treated with radiation and ADT (ADT is androgen deprivation therapy). Up to 30% of these cancers recur within 5 years of …

Cancer Of Prostate

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT05361798

Phase 2

A Phase 2 Randomized, Dose-Masked Study of Intravitreal EYE103 in Participants With Neovascular Age-Related Macular Degeneration (NVAMD) or Macular Edema Following Branch Retinal Vein Occlusion (BRVO)

EYE-RES-104 is a randomized, dose-masked study of intravitreal remigromig (EYE103) in participants with neovascular age-related macular degeneration (NVAMD) or…

Neovascular Age-Related Macular Degeneration (NVAMD)Branch Retinal Vein Occlusion (BRVO)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

EyeBiotech Ltd.NCT07205887

Phase 2

A Phase 2 Randomized Double-blind Placebo-controlled Study To Evaluate The Efficacy And Safety Of Adjunctive Recombinant Human Plasma Gelsolin With Standard Care For Moderate-to-Severe ARDS Due To Pneumonia Or Other Infections

BTI-203 is a randomized, double-blind, placebo-controlled, multicenter, Phase 2 proof-of-concept (POC) study to evaluate the efficacy and safety of rhu-pGSN pl…

Acute Respiratory Distress SyndromeInfections

Estimated

~$75 – $2,800

Actual pay is set by the research site.

BioAegis Therapeutics Inc.NCT05947955

Phase 3

A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS

The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germs that can…

Pneumococcal Disease

Estimated

~$50 – $2,250

Actual pay is set by the research site.

PfizerNCT07629440